HeadlinesBriefing favicon HeadlinesBriefing

Private Equity 8 Hours

×
18 articles summarized · Last updated: LATEST

Last updated: June 12, 2026, 2:30 PM ET

Healthcare M&A

Secured Piccolo Medical as Spectrum Vascular, backed by SK Capital, added a niche vascular‑access platform to its product suite, expanding the group’s addressable market in medication‑delivery devices. Across the Alps, acquired Compet Medical gave Healthcare Holding Schweiz, supported by KKA and Winterberg, a foothold in harm‑reduction supplies for public‑sector clients, reinforcing a broader trend of PE firms consolidating fragmented med‑tech distributors.

Fundraising & Liquidity

Carlyle targeted $15bn for its ninth flagship buyout fund signalling confidence in deal flow despite elevated financing costs, while capped redemptions on a $13bn private‑credit vehicle for the second consecutive quarter as BlackRock responded to heightened retail outflows. In parallel, promoted Anton Orlich to oversee private‑markets investing at Cal PERS, underscoring the pension fund’s focus on preserving strong PE returns after a year of outperformance relative to public markets.

Tech‑Focused Capital Moves

Invested in Crowe’s advisory arm marked KKR’s first institutional stake in the CPA firm, expanding the firm’s capacity to cross‑sell advisory services to mid‑market clients and diversifying KKR’s exposure to high‑margin professional‑services assets. Meanwhile, the SpaceX IPO set a record with a valuation near $1.8tn, delivering an estimated $5bn windfall to early backers such as Founders Fund, Sequoia and Andreessen Horowitz, a payout that could fuel a new wave of large‑scale private‑market exits. The same offering generated historic gains for venture investors, illustrating how a single public listing can reshape capital allocation across both venture and traditional private‑equity ecosystems.